Ontology highlight
ABSTRACT: Purpose
Genome-wide association studies and targeted sequencing studies of candidate genes have identified common and rare variants that are associated with age-related macular degeneration (AMD). Whole-exome sequencing (WES) studies allow a more comprehensive analysis of rare coding variants across all genes of the genome and will contribute to a better understanding of the underlying disease mechanisms. To date, the number of WES studies in AMD case-control cohorts remains scarce and sample sizes are limited. To scrutinize the role of rare protein-altering variants in AMD cause, we performed the largest WES study in AMD to date in a large European cohort consisting of 1125 AMD patients and 1361 control participants.Design
Genome-wide case-control association study of WES
SUBMITTER: Corominas J
PROVIDER: S-EPMC6104593 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature